The impact of total bilirubin on plasma micafungin levels in living- donor liver transplantation recipients with severe liver dysfunction

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 4, 2009, Pages 750-754

  Muraki, Yuichi ^a   Iwamoto, Takuya ^a   Kagawa, Yoshiyuki ^a,b   Sakurai, Hiroyuki ^c   Usui, Masanobu ^c   Isaji, Shuji ^c   Uemoto, Shinji ^d   Okuda, Masahiro ^a  

^a MIE UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c MIE UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Fungal infection; Hyperbilirubinemia; Living donor liver transplantation; Micafungin; Therapeutic drug monitoring

Indexed keywords

BILIRUBIN; MICAFUNGIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY FUNCTION; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MYCOSIS; POSTOPERATIVE INFECTION; SYMPTOM;

ANTIFUNGAL AGENTS; BILIRUBIN; DRUG MONITORING; ECHINOCANDINS; FEMALE; HUMANS; HYPERBILIRUBINEMIA; LIPOPEPTIDES; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED;

EID: 65249143915     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.750     Document Type: Article

References (27)

1. Chiou C. C., Groll A. H., Walsh T. J., Oncologist, 5, 120-135 (2000).
2. Tomishima M., Ohki H., Yamada A., Takasugi H., Maki K., Tawara S., Tanaka H., J. Antibiot., 52, 674-676 (1999).
3. Ikeda F., Wakai Y., Matsumoto S., Maki K., Watabe E., Tawara S., Goto T., Watanabe Y., Matsumoto F., Kuwahara S., Antimicrob. Agents Chemother., 44, 614-618 (2000).
4. van Burik J. A., Ratanatharathorn V, Stepan D. E., Miller C. B., Lipton J. H., Vesole D. H., Bunin N., Wall D. A., Hiemenz J. W., Satoi Y., Lee J. M., Walsh T. J., Clin. Infect. Dis., 39, 1407-1416 (2004).
5. Yanada M., Kiyoi H., Murata M., Suzuki M., Iwai M., Yokozawa T., Baba H., Emi N., Naoe T., Intern. Med., 45, 259-264 (2006).
6. Kohno S., Masaoka T., Yamaguchi H., Mori T., Urabe A., Ito A., Niki Y., Ikemoto H., Scand. J. Infect. Dis., 36, 372-379 (2004).
7. Ostrosky-Zeichner L., Kontoyiannis D., Raffalli J., Mullane K. M., Vazquez J., Anaissie E. J., Lipton J., Jacobs P., van Rensburg J. H., Rex J. H., Lau W., Facklam D., Buell D. N., Eur. J. Clin. Microbiol. Infect. Dis., 24, 654-661 (2005).
8. Kuse E. R., Chetchotisakd P., da Cunha C. A., Ruhnke M., Barrios C., Raghunadharao D., Sekhon J. S., Freire A., Ramasubramanian V, D emeyer I., Nucci M., Leelarasamee A., Jacobs F., Decruyenaere J., Pittet D., Ullmann A. J., Ostrosky-Zeichner L., Lortholary O., Koblinger S., Diekmann-Berndt H., Cornely O. A., Lancet, 369, 1519-1527 (2007).
9. Hebert M. F., Smith H. E., Marbury T. C., Swan S. K., Smith W. B., Townsend R. W., Buell D., Keirns J., Bekersky I., J. Clin. Pharmacol., 45, 1145-1152 (2005).
10. Denning D. W., Lancet, 362, 1142-1151 (2003).
11. Ostrosky-Zeichner L., Rex J. H., Pappas P. G., Hamill R. J., Larsen R. A., Horowitz H. W., Powderly W. G., Hyslop N., Kauffman C. A., Cleary J., Mangino J. E., Lee J., Antimicrob. Agents Chemother., 47, 3149-3154 (2003).
12. Azuma J., Nakahara K., Kagayama A., Kajiho T., Kawamura A., Suematsu H., Mukai T., Jpn. J. Chemother., 50, 148-154 (2002).
13. Yamato Y., Kaneko H., Tanimoto K., Katashima M., Ishibashi K., Kawamura A., Terakawa M., Kagayama A., Jpn. J. Chemother., 50, 68-73 (2002).
14. Kiuchi T., Tanaka K., Jpn. J. Med. Mycol., 42, 189-193 (2001).
15. Shimoeda S., Ohta S., Kobayashi H., Yamato S., Sasaki M., Kawano K., Biol. Pharm. Bull., 29, 1886-1891 (2006).
16. Ouchi H., Fujita M., Ikegame S., Inoshima I., Harada E., Nakanishi Y., J. Infect. Chemother., 13, 258-262 (2007).
17. Ota Y., Tatsuno K., Okugawa S., Yanagimoto S., Kitazawa T., Fukushima A., Tsukada K., Koike K., J. Infect. Chemother., 13, 208-212 (2007).
18. Kishino S., Ohno K., Shimamura T., Furukawatodo H., Clin. Transplant., 18, 676-680 (2004).
19. Takeda K., Morioka D., Matsuo K., Endo I., Sekido H., Moroboshi T., Togo S., Shimada H., Transplant. Proc., 39, 3505-3508 (2007).
20. Mochizuki N., Matsumoto K., Ohno K., Shimamura T., Furukawa H., Todo S., Kishino S., Transplant. Proc., 38, 3649-3650 (2006).
21. Tabata K., Katashima M., Kawamura A., Tanigawara Y., Sunagawa K., Biol. Pharm. Bull., 29, 1706-1711 (2006).
22. Nakagawa Y., Ichii Y., Saeki Y., Kodaka M., Suzuki K., Kishino S., J Infect. Chemother., 13, 39-45 (2007).
23. Seibel N. L., Schwartz C., Arrieta A., Flynn P., Shad A., Albano E., Keirns J., Lau W. M., Facklam D. P., Buell D. N., Walsh T. J., Antimicrob. Agents Chemother., 49, 3317-3324 (2005).
24. Shimoeda S., Ohta S., Kobayashi H., Saitou H., Kubota A., Yamato S., Shimada K., Sasaki M., Kawano K., Biol. Pharm. Bull., 28, 477-480 (2005).
25. Abe F., Ueyama J., Kawasumi N., Nadai M., Hayashi T., Kato M., Ohnishi M., Saito H., Takeyama N., Hasegawa T., Antimicrob. Agents Chemother., 52, 3454-3456 (2008).
26. Abe F., Ueyama J., Kimata A., Kato M., Hayashi T., Nadai M., Saito H., Takeyama N., Noguchi H., Hasegawa T., Life Sci., 83, 229-235 (2008).
27. Jedlitschky G., Leier I., Buchholz U., Hummel-Eisenbeiss J., Burchell B., Keppler D., Biochem. J., 327, 305-310 (1997).